Abstract Body

Human immunodeficiency virus (HIV) can adapt to an individual’s T cell immune response via genetic mutations that affect antigen recognition and impact disease outcome. In vaccine design, it is vital to understand this complex host-viral interaction including the mechanisms that underpin viral adaptations that subvert/alter the immune response. In this study, we assign the putative replicative cost and immune benefit of specific HIV adaptations in the unique setting of vertical HIV transmission. Single cell transcriptomics of antigen-specific T cells was also utilised to further delineate the dynamics of specific adaptations that may reflect a novel mechanism of adaptation. These results could be used to inform vaccine designs and cure strategies to combat the issue of immune adaptation.

Specifically, we utilised a deep sequencing approach to determine the HIV quasispecies in 26 mother/child transmission pairs where the potential for founder viruses to be pre-adapted is high. The resultant sequences and previously determined viral adaptations for specific host genotypes were used to generate adaptation scores for the transmitted virus. We used intra-cellular cytokine staining to assess specific antigen-specific T cell immune responses and single cell technologies to compare T cell receptor (TCR) repertoire and transcriptome data for a specific HIV epitope in which adaptation is associated with continued immune recognition.

We showed that the dynamics of HIV adaptations following transmission provides insight into the in vivo replicative cost associated with specific adaptations with limited evidence for reversion of adaptations in non-selective environments suggestive of extensive compensatory networks. The antigen-specific T cell responses in the child overall suggested the immune response to the heavily pre-adapted HIV strains may focus on sub-dominant T cell epitopes as evidenced by de novo adaptation following transmission. Interestingly, there was evidence of cross-reactive T cells to the adapted and non-adapted form of an epitope at the TCR family level for the mother/child pair, but this did not extend to the α/β CDR3. Unsupervised clustering of scRNAseq data separated cells stimulated by the adapted and non-adapted forms, with common differentially expressed genes upregulated in both the mother and child.

Such targets will be important in the development of a therapeutic vaccine for individuals that have an established reservoir of adapted virus.